SCHEMBL11301418

SCHEMBL11301418

O=C(NO)c1ccc(N(c2cccc3ccc(=O)[nH]c23)C2CCNC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 10/20 0.39
▸ SLC6A2 P23975 9/20 0.39
▸ SLC6A3 Q01959 7/20 0.39
▸ KCNH2 Q12809 3/20 0.36
▸ CA12 O43570 3/20 0.34
▸ CA9 Q16790 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11299962 0.87 SLC6A4 (0.39) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11294789 0.85 BRD4 (0.50) SLC6A4SLC6A2
SCHEMBL11304997 0.84 HDAC6 (0.33) SLC6A4SLC6A2SLC6A3KCNH2KDM4E
SCHEMBL11306334 0.77 HDAC1 (0.45) SLC6A4SLC6A2SLC6A3KCNH2CA12
SCHEMBL11298741 0.75 SLC6A4 (0.45) SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL11301824 0.74 KDM4E (0.39) SLC6A4SLC6A2SLC6A3KDM4EMEN1
SCHEMBL11300763 0.74 HDAC8 (0.42) KDM4EMEN1LMNAALOX15ALOX12
SCHEMBL11304366 0.72 SLC6A2 (0.44) SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL11294920 0.70 KDR (0.39) SLC6A4SLC6A2SLC6A3HDAC8HDAC6
SCHEMBL11302583 0.68 SLC6A2 (0.53) SLC6A4SLC6A2SLC6A3KCNH2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback